Since Folkman proposed that tumours cannot grow beyond 2 to 3 mm in size without forming new blood vessels1, tumour angiogenesis has been a critical target of cancer therapy; substantial evidence has indicated that vascular endothelial growth factor (VEGF) plays an essential role in developmental angiogenesis. Here, VEGFA is linked to cancer.